Advertisements

Interferon Beta reduced risk of severe Covid by 80%

Welcome to the Era of the Anti-Virals. They’re everywhere.

A legacy of the coronavirus pandemic is the dawn of new ways to stop viruses. Here’s another new (old) one — it’s only a small trial, but if it can stop 4 out of 5 people developing the severe form of the disease it will be a gamechanger. If this gets similar numbers on larger trials, then we still need mass production. But national policies will swing on a dime if a safe drug with this much potential appears.

After Coronavirus we might not be so content to accept the annual seasonal virus scourge.

Breakthrough’ treatment slashes virus death risk: study

by Patrick Galey, MedicalXpress

In a randomised trial of 100 patients admitted to hospital with COVID-19, those who received an inhaled formula of the protein interferon beta were at 79 percent lower risk of developing severe disease compared to those who received a placebo.

They were also more than twice as likely to make a full recovery compared with the control group.

The firm behind the treatment, known as SNG001, said the preliminary results suggested “a major breakthrough” in the pandemic.

Interferon […]Rating: 0.0/10 (0 votes cast)

via JoNova

https://ift.tt/2BhEPpZ

July 20, 2020 at 12:36PM